All In Biotech

Drug Trial Radar · NCT00804375

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain

Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain.

Last checked: Nov 19, 2026Latest source record: Mar 24, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

150

Planned (sponsor's estimate)

Start

Dec 2008

Primary completion

Jun 2010

Study completion Jun 2010

Sponsor

Lead sponsor
Smerud Medical Research International ASAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
SantoSolve AS
First posted
Dec 8, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary: To compare the analgesic effect over 12 weeks of topical 2PX in stump pain. Secondary: To prospectively measure other efficacy and safety variables of topical 2PX in stump pain. Exploratory analyses will be performed to measure efficacy and safety variables of topical 2PX in phantom pain

Conditions

  • Stump Pain

Interventions

  • 2PXDrug

    cutaneous solution to be applied twice daily for 84 days

  • PlaceboDrug

    cutaneous solution to be applied twice daily for 84 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Average (stump) Pain Intensity (AsPI): and recorded in the diary in response to the question: 'What was your average stump pain intensity over the past 24 hours?' on a 100 mm VAS (0 = no pain, 100 = worst pain imaginable).Time frame: will be measured each evening (at least 1 hour after taking off the prosthesis, if applicable, and immediately prior to administering the evening dose of study medication)

Locations

19 sites in 5 countries. Site status is shown where the registry gives one.

  • Site in Århus

    Aarhus, Denmark · Completed

  • Site in Herlev

    Herlev, Denmark · Completed

  • Site in Hvidovre

    Hvidovre, Denmark · Completed

  • Site in Wiesbaden

    Wiesbaden, Germany · Recruiting

  • Site in Ålesund

    Ålesund, Norway · Completed

  • Site in Hamar

    Hamar, Norway · Completed

  • Site in Oslo

    Oslo, Norway · Completed

  • Site in Stavern

    Stavern, Norway · Completed

  • Site in St. Petersburg

    Saint Petersburg, Russia · Recruiting

  • Site in St.Petersburg

    Saint Petersburg, Russia · Recruiting

  • Site in Belfast

    Belfast, United Kingdom · Completed

  • Site in Birmingham

    Birmingham, United Kingdom · Completed

  • Site in Edinburgh

    Edinburgh, United Kingdom · Completed

  • Site in Glasgow

    Glasgow, United Kingdom · Completed

  • Site in Hammersmith

    Hammersmith, United Kingdom · Completed

  • Site in Crystal Palace

    London, United Kingdom · Completed

  • Site in Manchester

    Manchester, United Kingdom · Completed

  • Site in Middlesborough

    Middlesbrough, United Kingdom · Completed

  • Site in Newcastle

    Newcastle, United Kingdom · Completed

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.